GREY:ATBPF - Post by User
Post by
Bookworm28on Jun 24, 2021 1:25pm
361 Views
Post# 33444659
Can they bring Otenaproxesul to market?
Can they bring Otenaproxesul to market?I apologize for asking the question, but I've emailed ATE's Investor Relations numerous times over the last year, and they haven't replied. So I'll ask...
Can the company link an H2S molecule onto someone else's NSAID (e.g. Aleve), and sell the resulting product? I know it must sound ridiculous, but like I said, the company isn't replying to my emails. Reading up on patents, and the law appears to state that if the resulting compound does not share any of the original characteristics of the original two compounds, that's acceptable. In the case of Otenaproxesul, you're obviously wanting the pain killing properties of Aleve to persist - No?
I'm no patent expert. I'm just having a hard time with the idea of tagging an H2S molecule onto someone else's NSAID, and calling it your own. I can't imagine Nuance putting up $20MM if this wasn't do-able.
I'd like to buy, and don't mind waiting, but this is a pretty basic question I'd like to get answered before I jump in.
Thanks